People · Operator
Named in public records as an officer, director or promoter · active 2021–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Optimeos Life Sciences, Inc. | — | Biotechnology | Seed | $3.4M | $24.9M | 2021 |
Jason K. Smith, PhD at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jason K. Smith, PhD on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Benjamin K. Doranz | 1 | 1 |
| Shahram Hejazi, PhD | 1 | 1 |
| Robert K. Prud'homme, PhD | 1 | 1 |
| Robert Prud'homme, PhD | 1 | 1 |
| Jason Smith, PhD | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.